Soluble endoglin and other circulating antiangiogenic factors in preeclampsia
Article Abstract:
The role of alteration of circulating soluble fms-like tyrosine kinase 1 (sFlt1), an antiangio gene protein, and a placental growth factor (P1GF), a proangiogenic protein in the pathogenesis of preeclampsia in women is examined. The results suggest that rising circulating levels of soluble endoglin and ratios of sFlt1:P1GF herald the onset of preeclampsia.
Publication Name: The New England Journal of Medicine
Subject: Health
ISSN: 0028-4793
Year: 2006
User Contributions:
Comment about this article or add new information about this topic:
Urinary placental growth factor and risk of preeclampsia
Article Abstract:
A study is conducted to test whether urinary placental growth factor (PIGF), a proangiogenic protein, is reduced prior to onset of hypertension and proteinuria, and whether this reduction predicts preeclampsia. The results indicate that decreased urinary PIGF at mid gestation is strongly associated with subsequent early development of preeclamsia.
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 2005
User Contributions:
Comment about this article or add new information about this topic:
Circulatinng angiogenic factors and the risk of preeclampsia
Article Abstract:
The development of preeclampsia can be predicted through increased levels of soluble fms-like tyrosine kinase 1 and reduced levels of placental growth factor. A controlled study within the calcium for preeclampsia prevention trial which involved healthy nulliparous women was conducted.
Publication Name: The New England Journal of Medicine
Subject: Health
ISSN: 0028-4793
Year: 2004
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Angiogenesis in life, disease and medicine. Regulation of angiogenesis by tissue factor cytoplasmic domain signaling
- Abstracts: To merge or not? Are you willing to pay the price? Doctors turn to management companies
- Abstracts: Serum aldosterone and the incidence of hypertension in nonhypertensive persons. Plasma natriuretic peptide levels and the risk of cardiovascular events and deaths